A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
| Autor: | Carlsson, G., Koumarianou, A., Guren, T.K., Haux, J., Katsaounis, P., Kentepozidis, N., Pfeiffer, P., Brændengen, M., Mavroudis, D., Taflin, H., Skintemo, L., Tell, R., Papadimitriou, C. |
|---|---|
| Zdroj: | In ESMO Open October 2022 7(5) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|